Eli Lilly launches nasal glucagon drug applications in Europe and US

Eli Lilly has submitted drug applications in Europe and the US for a new nasal glucagon to treat severe hypoglycemia. If approved the drug could be the first nasal dry powder spray available to treat severe hypos in adults and children with diabetes. Nas https://www.diabetes.co.uk/news/2018/jul/eli-lilly-launches-nasal-glucagon-drug-applications-in-europe-and-us-98411875.html